ecrin-mdr-crcClinical2023Esophageal carcinomaCarcinomaEpithelial Tumors, MalignantNon-small cell lung cancerColorectal cancerNeoplasms, Glandular and EpithelialCervical cancerNeoplasms, Glandular And EpithelialEsophageal CarcinomaCarcinomaCervical CancerEpithelial Tumors, MalignantNon-small Cell Lung CancerColorectal CancerInterventionalhttps://newmdr.ecrin.org/Study/68117Australia8Urothelial cancerMyeloid cellsAnti-TROP-2 chimeric antigen receptorPancreatic ductal adenocarcinomaGastric adenocarcinomaChimeric Antigen Receptor (CAR)HR+/HER2- breast cancerTriple-negative breast cancerMonocytesMT-302TROP-2 expressing tumorsOvarian epithelialLipid nanoparticle (LNP)MRNAECRIN MDRRecruitingfalseStudy of MT-302 in Adults With Advanced or Metastatic Epithelial TumorsMYE Symphony is a multicenter, open-label, Phase 1 first-in-human study to assess the safety, tolerability, and define the RP2D of MT-302 in participants with advanced epithelial cancer.2023-08-1568117NCT05969041